Ir al contenido

Political Economy of Medicine Access and Effective Coverage in a Fragmented Health System

Institutional fragmentation across health financing and pharmaceutical governance systematically undermines the conversion of nominal insurance enrollment into reliable access to essential medicines. State infrastructural capacity, strategic purchasing mechanisms, and unified regulatory oversight are fundamental prerequisites for mitigating out-of-pocket drug burdens and structural inequities in multi-tiered health systems. Aligning pharmaceutical policy with broader social protection reforms is essential to securing effective coverage and financial risk protection across diverse socio-economic groups.

Objetivo

To examine how political economy factors and structural fragmentation shape the translation of statutory health coverage into effective, equitable access to essential medicines.

Metodología

Comparative policy analysis and secondary document synthesis of health financing frameworks, medicine pricing regulations, and coverage records across multi-tiered systems.

Novedad científica

Demonstrates how fragmented risk pooling and state infrastructural deficits systematically decouple nominal insurance expansion from physical medicine availability and financial protection.

Vista previa del documento

Esta es una vista previa breve. La versión completa incluye texto ampliado para todas las secciones, una conclusión y una bibliografía formateada.

PhD Dissertation

Degree:
Political Economy of Medicine Access and Effective Coverage in a Fragmented Health System

Author:

Group

First M. Last

Advisor:

Dr. First Last

City, 2026

Contents

Carátula
Declaración de Uso de IA
Abstract
Introduction
Chapter 1. Political Economy Foundations of Health Financing and Medicine Access
1.1 Structural Fragmentation and Institutional Asymmetries in Mixed Health Systems
1.2 State Infrastructural Power and Strategic Purchasing in Medicine Provision
1.3 Conceptual Disconnect Between Nominal Coverage and Effective Medicine Access
1.4 Pharmaceutical Governance, Pricing Regulations, and Distributional Politics
Chapter 2. Methodological Framework and Comparative System Design
2.1 Comparative Policy Analysis of Fragmented Risk Pooling Mechanisms
2.2 Evaluation Criteria for Pharmaceutical Supply Chains and Essential Medicine Lists
2.3 Secondary Data Synthesis on Household Out-of-Pocket Expenditure and Medicine Stock-Outs
2.4 Methodological Boundaries, Validity Controls, and Data Limitations
Chapter 3. Institutional Determinants of Pharmaceutical Reform and Supply Security
3.2 Price Regulation Schemes, Cross-Subsidization, and Fiscal Sustainability
3.3 Supply Chain Bottlenecks, Last-Mile Delivery, and Depletion Dynamics in Primary Care
3.4 Public-Private Provider Interactions and Market Distortions in Medicine Delivery
Chapter 4. Coverage Expansion Across Segmented Populations and Labor Regimes
4.2 Persistent Inequities in Benefit Packages Across Socio-Economic Strata
4.3 Co-Payment Burdens, Catastrophic Drug Costs, and Unmet Pharmaceutical Need
4.4 Vulnerable Groups, Marginalized Communities, and Structural Exclusions
Chapter 5. Post-Disruption System Resilience and Health System Governance
5.1 Macroeconomic Shocks, Emergency Financing, and Pharmaceutical Budget Vulnerability
5.2 Strategic Purchasing and Interoperable Health Information Infrastructure
5.3 Accountability Mechanisms, Regulatory Capture, and Informal Copayments
Chapter 6. Policy Trajectories for Effective Pharmaceutical Coverage
6.1 Structural Consolidation of Fragmented Risk Pools and Universal Benefits
6.2 Reforming Payment Models and Centralized Procurement for Essential Drugs
6.3 Harmonizing Multi-Tiered Social Protection and Primary Healthcare Delivery
Discusión
Conclusion
Bibliography

Introduction

Health system fragmentation constitutes a profound institutional obstacle to realizing universal health coverage, as divided risk pools and uncoordinated regulatory structures undermine equitable access to essential therapeutics. While statutory enrollment initiatives have expanded across low- and middle-income countries, formal entitlement frequently fails to guarantee reliable service delivery, particularly when supply chain logistics and pharmaceutical financing remain disarticulated [1], [5]. Under conditions of institutional segmentation, medicine shortages and fragmented purchasing power shift financial burdens directly back onto vulnerable households [3], [6].

The fundamental dilemma in fragmented health regimes lies in the divergence between nominal insurance coverage and effective pharmaceutical provision. Multi-tiered public schemes and uneven regulatory enforcement frequently allow market asymmetries, regional disparities, and informal financial barriers to persist, diluting the protective efficacy of health policy reforms [2], [4]. Consequently, expanding entitlement without simultaneous institutional consolidation and robust infrastructural capacity often exacerbates structural inequities between formal wage-earners and informal populations [1], [5].

This dissertation evaluates how political economy determinants, institutional capacity, and financing mechanisms govern medicine access and effective coverage within segmented health architectures. Utilizing a comparative secondary policy analysis of health financing instruments, pharmaceutical procurement frameworks, and health system performance indicators across diverse reform settings, the inquiry establishes rigorous criteria for bridging the divide between statutory inclusion and tangible clinical delivery [2], [3], [5]. The resulting synthesis contributes critical insights into designing resilient, equity-oriented pharmaceutical governance models [6].

2.1 Comparative Policy Analysis of Fragmented Risk Pooling Mechanisms

To evaluate the institutional divergence between statutory health coverage and realized pharmaceutical access in segmented health systems, this methodological design applies a rigorous comparative secondary data synthesis across multi-tiered health jurisdictions. The analytical framework systematically reviews and evaluates national medicine policies, national health sector strategic frameworks, and multilateral global health databases to assess the governance mechanisms that structure essential medicine pricing, sustainable financing, and regulatory supply chain systems (Asare et al., 2023). Document analysis is methodologically combined with secondary health system datasets to trace how fragmented risk pools restrict equitable cross-subsidization and dilute state purchasing leverage against pharmaceutical suppliers (SSRN, 2026). This stratified analytical approach isolates institutional and regulatory asymmetries within mixed public-private delivery networks, capturing how disjointed provider payment models and volatile financing arrangements perpetuate household out-of-pocket costs and informal payments despite widespread nominal insurance enrollment (SSRN, 2026). Furthermore, the research methodology categorizes institutional policy interventions across three core analytical dimensions: evidence-based medicine selection, fiscal-technical resource alignment, and supply chain regulatory capacity (Asare et al., 2023). By systematically harmonizing qualitative policy trajectories with comparative secondary indicators of service availability and system stress, the empirical framework controls for cross-jurisdictional reporting variance while elucidating how institutional depth and strategic purchasing shape effective coverage (SSRN, 2026). Consequently, this methodological architecture provides a reproducible comparative foundation to examine why health insurance expansion fails to guarantee dependable medicine delivery and equitable financial protection in fragmented welfare regimes.

References

  1. The Political Economy of Health Insurance Enrolment in Ethiopia: Party, State and the Quest for Universal Health Coverage
    Tom Lavers
    Enlace DOI
  2. How and why pharmaceutical reforms contribute to universal health coverage through improving equitable access to medicines: a case of Ghana
    Augustina Koduah
    Enlace DOI
  3. Does Universal Health Coverage Improve Access to Healthcare? Insights from Rwanda’s National Health System
    Musinga Abdulswamad
    Enlace DOI
  4. Sustaining Universal Health Coverage in Vietnam: Expanding Health Coverage for Informal Economy Workers
    Duc Trong Pham
  5. Translating Coverage into Access: Evidence-Based Analysis of Universal Health Coverage Across Low-and Middle-Income Countries Post-COVID
    Swalin Suraj Pradhan
  6. Universal Health Coverage
    K. Srinath Reddy, Manu Raj Mathur
  7. TOWARDS UNIVERSAL HEALTH COVERAGE: ACCESS AND UTILIZATION OF HEALTH CARE SERVICES IN BHUTAN
    Tshering Wangdi
  8. Could universal health care coverage restrict access? The mixed effects of universal coverage on minorities' receipt of obstetric care in northern Thailand
    Stephanie M Koning

Bibliografía

Fuentes VerificadasNormas de FormatoAlta OriginalidadModelos Pro
🔥 25% OFF

Disertación

APA 7ª Edición (con adaptación "y otros")

US$ 26US$ 34
  • 120+ páginas
  • Alta originalidad
  • Exportar a Word
  • Formato correcto
  • Vista previa pública
    La vista previa de otro autor no puede hacerse privada. Tu trabajo será privado y completamente único.
  • Bibliografía (100+, APA 7ª Edición)
    +US$ 1
  • Añadir fuentes alternativas (Noticias, .gov, .edu)

Disertación

APA 7ª Edición (con adaptación "y otros")